Tislelizumab
Records for this ingredient, by country (identity only).
ATC L01FF09 · 11 markets · 16 records
US 3 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedinjectionTEVIMBRAManufacturer: Novartis Pharma Stein AG
AU 3 records · 2 shown of 2
- 100 mg/10 mLinjectionTEVIMBRA
- 100 mg per mL / per unit basis not statedinjectionTEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 1 records · 1 shown of 1
- 100 mg/10 mLinjectionTevimbra 100mg/10ml concentrate for solution for infusion vials
CA 1 records · 1 shown of 1
- 10 mg/1 mLliquidTEVIMBRA
SG 1 records · 1 shown of 1
- 100 mg/10 mLinjectionTEVIMBRA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML
CN 1 records · 1 shown of 1
- 100 mg/10 mLinjection百泽安替雷利珠单抗
ES 1 records · 1 shown of 1
- 100 mg per mL / per unit basis not statedinjectionTEVIMBRA
TW 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 1 records · 1 shown of 1
- 100 mg/10 mLinjectionテビムブラ点滴静注100mg
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | JP | EU |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 mg/10 mL injection | Tevimbra 100mg/10ml concentrate for solution for infusion vials | TEVIMBRA | TEVIMBRA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML | 百泽安替雷利珠单抗 | テビムブラ点滴静注100mg | ||||||
| 100 mg per mL / per unit basis not stated cannot compare injection | TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial | TEVIMBRA | |||||||||
| 10 mg per mL / per unit basis not stated cannot compare injection | Manufacturer: Novartis Pharma Stein AG TEVIMBRA | ||||||||||
| 10 mg/1 mL liquid | TEVIMBRA | ||||||||||
unknown | TEVIMBRA | TEVIMBRA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML | TEVIMBRA | ||||||||
injection | Tevimbra Concentrated Solution for Infusion 汰瘤安注射劑 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in CA and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 CA 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 CA 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.